Latest news
02 Dec, 2019 · In News
Robotic gloves enable Joakim to work again
13 Nov, 2019 · In Press Releases
Bioservo has finished a successful long term trial with Toyota Motor North America
World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies
Master of Science in Business Administration and Economics from the Uppsala University. Has 25 years of experience as CFO alongside with growth related operational responsibilities. He has been working under private equity regimes as well as in both listed and privately held companies, e.g CFO assignments at the Phadia group, 2005-2011, as well as Iggesund Paperboard, Trelleborg Industries and Observer/Cision. Today he is the Chairman of Tellacq AB and Bioservo Technologies AB and member of the Board of Antrad Medical, Motion Display and Secure Appbox.
Dependent in relation to the company's major owners.
Entry: 2016
Holding: 948 080 shares as well as 1600 warrants
One of the three founders of the company and board member. M.D., Ph.D. Professor em. in Neuronic engineering, KTH-Royal Institute of Technology and Senior Neurosurgeon em, Karolinska University Hospital. During 1994-2007 Hans von Holst was appointed as a member of the WHO division group focusing on head injury prevention. He has over 150 original research publications, book chapters and books. Based on his experience from clinical neurosurgery and applied neuro-engineering he has initiated an innovation-driven research education that has resulted in six spin-off ventures.
Dependent in relation to the company and its management.
Entry: 2014
Holding: 72 326 shares as well as 3200 warrants
Master of Science in Business from Lund University, Sweden. Background in accounting at various accounting firms. CFO at Nycomed Pharma AS from 1997 until 2011. Currently, Runar is COB of ConceptoMed AS, a Norwegian MedTech Company and is Board member of Bioservo Technologies AB, Norsk Kjededrift AS, SE Holding AS and acts as a consultant and member of the Audit Committee of Acino, a Swiss Pharmaceutical Company.
Dependent in relation to the company's major owners.
Entry: 2016
Holding: 1600 warrants
Master of Science in Industrial Engineering and Management from Chalmers University of Technology. Has over 20 years experience from senior management positions in both multinational corporations and startup companies, for instance as CEO for Peepoople, Director of Business Development and Marketing with Capio, and Business Development Manager and Head of Product Area with Tetra Pak. Today she works mainly with innovative startups and growth companies, including as Business Coach at Sting (Stockholm Innovation & Growth AB).
Independent.
Entry: 2017
Holding: 2500 warrants
BA/MA in Economics from Cambridge University and MBA in Finance from the Wharton School at the University of Pennsylvania. Kunal is a healthcare-focused private equity investor, with experience of investing in small and mid-cap companies across Europe and North America. He has worked previously at Avista Capital Partners, DLJ Merchant Banking Partners and Lehman Brothers. He is currently a Board member of Nordic BioSite, Acino International and Trimb Healthcare, and was previously a Board member of ConvaTec and Guala Closures.
Dependent of the company's major owners.
Entry: 2018
Nikolaj Sørensen
Master of Science in Economics from the Stockholm School of Economics as well as the Copenhagen Business School. Nikolaj is currently President and CEO of Orexo AB, a publicly Swedish specialty pharmaceutical company. Nikolaj has been CEO of Orexo AB since 2013 and has contributed to the establishment of Orexo in the US and the transformation of Orexo from development companies to a company in a commercial phase. Before Orexo, he has worked many years in senior positions and as an advisor in life science in Sweden and internationally.
Independent.
Entry: 2019
Holding: 6762 shares
